The Value of Genetic and Genomic Technologies (häftad)
Fler böcker inom
Format
Häftad (Paperback / softback)
Språk
Engelska
Antal sidor
108
Utgivningsdatum
2010-12-29
Förlag
National Academies Press
Medarbetare
Wizemann, Theresa (gen. rapporteur)/Berger, Adam C. (gen. rapporteur)/Wizemann, Theresa (gen. rapporteur)/Berger, Adam C. (gen. rapporteur)
Dimensioner
234 x 158 x 6 mm
Vikt
181 g
Antal komponenter
1
ISBN
9780309157711

The Value of Genetic and Genomic Technologies

Workshop Summary

av Institute Of Medicine, Board On Health Sciences Policy, Roundtable On Translating Genomic-Based Research For Health, Adam C Berger, Theresa Wizemann
Häftad,  Engelska, 2010-12-29
465
Köp
Spara som favorit
  • Skickas från oss inom 5-8 vardagar.
  • Fri frakt över 249 kr för privatkunder i Sverige.
Finns även som
Visa alla 2 format & utgåvor
Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice. Table of Contents Front Matter 1 Introduction 2 Tumor-Based Screening for Lynch Syndrome 3 Pharmacogenomic Testing to Guide Warfarin Dosing 4 Genomic Profiling 5 Closing Remarks References Appendix A: Workshop Agenda Appendix B: Speaker Biographical Sketches Appendix C: Lynch Syndrome Topic Brief Appendix D: Warfarin Topic Brief Appendix E: Genomic Profiling Topic Brief
Visa hela texten

Passar bra ihop

  1. The Value of Genetic and Genomic Technologies
  2. +
  3. Bad Therapy

De som köpt den här boken har ofta också köpt Bad Therapy av Abigail Shrier (inbunden).

Köp båda 2 för 730 kr

Kundrecensioner

Har du läst boken? Sätt ditt betyg »

Fler böcker av författarna

Institute Of Medicine, Board On Health Sciences Policy, Roundtable On Translating Genomic-Based Research For Health, Adam C Berger, Theresa Wizemann

Innehållsförteckning

1 Front Matter; 2 1 Introduction; 3 2 Tumor-Based Screening for Lynch Syndrome; 4 3 Pharmacogenomic Testing to Guide Warfarin Dosing; 5 4 Genomic Profiling; 6 5 Closing Remarks; 7 References; 8 Appendix A: Workshop Agenda; 9 Appendix B: Speaker Biographical Sketches; 10 Appendix C: Lynch Syndrome Topic Brief; 11 Appendix D: Warfarin Topic Brief; 12 Appendix E: Genomic Profiling Topic Brief

Du kanske gillar